Evidence map›Paper›PMID 28698718›Full record

ReviewStem cells international2017

The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential Applications.

Roberto Berebichez-Fridman, Ricardo Gómez-García, Julio Granados-Montiel, Enrique Berebichez-Fastlicht, Anell Olivos-Meza, Julio Granados, Cristina Velasquillo, Clemente Ibarra

Abstract readReview
In one paragraph

Review in Stem cells international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roberto Berebichez-FridmanTissue Engineering, Cell Therapy and Regenerative Medicine Unit, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Calzada México Xochimilco, No. 289, Col. Arenal de Guadalupe, 14389 Mexico City, Mexico.
Ricardo Gómez-GarcíaTissue Engineering, Cell Therapy and Regenerative Medicine Unit, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Calzada México Xochimilco, No. 289, Col. Arenal de Guadalupe, 14389 Mexico City, Mexico.
Julio Granados-MontielTissue Engineering, Cell Therapy and Regenerative Medicine Unit, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Calzada México Xochimilco, No. 289, Col. Arenal de Guadalupe, 14389 Mexico City, Mexico.ORCID 0000-0002-0611-6421
Enrique Berebichez-FastlichtDepartment of Orthopedic Surgery, American British Cowdray Medical Center, Av. Carlos Graef Fernández, No. 154, Col. Santa Fe, Cuajimalpa, 05300 Mexico City, Mexico.
Anell Olivos-MezaOrthopedic Sports Medicine and Arthroscopy Division, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Calzada México Xochimilco, No. 289, Col. Arenal de Guadalupe, 14389 Mexico City, Mexico.
Julio GranadosDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Av. Vasco de Quiroga, No. 15, Tlalpan, Belisario Domínguez Sección XVI, 14080 Mexico City, Mexico.
Cristina VelasquilloDirection of Research, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Calzada México Xochimilco, No. 289, Col. Arenal de Guadalupe, 14389 Mexico City, Mexico.
Clemente IbarraGeneral Direction, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Calzada México Xochimilco, No. 289, Col. Arenal de Guadalupe, 14389 Mexico City, Mexico.ORCID 0000-0002-4472-0435

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Only select tissues and organs are able to spontaneously regenerate after disease or trauma, and this regenerative capacity diminishes over time. Human stem cell research explores therapeutic regenerative approaches to treat various conditions. Mesenchymal stem cells (MSCs) are derived from adult stem cells; they are multipotent and exert anti-inflammatory and immunomodulatory effects. They can differentiate into multiple cell types of the mesenchyme, for example, endothelial cells, osteoblasts, chondrocytes, fibroblasts, tenocytes, vascular smooth muscle cells, and sarcomere muscular cells. MSCs are easily obtained and can be cultivated and expanded in vitro; thus, they represent a promising and encouraging treatment approach in orthopedic surgery. Here, we review the application of MSCs to various orthopedic conditions, namely, orthopedic trauma; muscle injury; articular cartilage defects and osteoarthritis; meniscal injuries; bone disease; nerve, tendon, and ligament injuries; spinal cord injuries; intervertebral disc problems; pediatrics; and rotator cuff repair. The use of MSCs in orthopedics may transition the practice in the field from predominately surgical replacement and reconstruction to bioregeneration and prevention. However, additional research is necessary to explore the safety and effectiveness of MSC treatment in orthopedics, as well as applications in other medical specialties.

Identifiers

PMID28698718
PMCPMC5494105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.